Subtopic Deep Dive
CRISPR Epigenome Editing
Research Guide
What is CRISPR Epigenome Editing?
CRISPR Epigenome Editing uses CRISPR-dCas9 fused to epigenetic modifiers for targeted gene activation, repression, or DNA demethylation without cutting DNA.
This approach repurposes catalytically inactive Cas9 (dCas9) with enzymes like TET1 for demethylation or DNMT3A for methylation. Key papers include Vojta et al. (2016) with 746 citations on targeted DNA methylation and Xu et al. (2016) with 368 citations on DNA demethylation. Over 10 provided papers span 2014-2022, focusing on applications in gene regulation.
Why It Matters
CRISPR Epigenome Editing enables reversible control of gene expression for studying non-coding regulation in development and cancer. Vojta et al. (2016) demonstrated targeted methylation to probe epigenetic marks' functional roles, while Choudhury et al. (2016) applied TET1-dCas9 to demethylate BRCA1 promoters in cancer models. Xu et al. (2016) showed selective demethylation tools for durable expression changes, impacting regenerative medicine as noted in Martello and Smith (2014) on stem cell pluripotency.
Key Research Challenges
Off-target epigenetic effects
dCas9 fusions can cause unintended methylation or demethylation at similar genomic sites. Vojta et al. (2016) reported widespread binding in epigenome editing attempts. Improving guide RNA specificity remains critical for precision.
Transient vs durable edits
Epigenetic changes often revert after modifier removal, limiting long-term applications. Xu et al. (2016) achieved temporary demethylation with TET1-dCas9. Strategies for stable, heritable modifications are needed for therapeutics.
Delivery in vivo
Efficient delivery of large dCas9-epigenetic effector complexes to target tissues challenges clinical use. Adli (2018) highlighted delivery as a barrier beyond genome editing. Viral vectors and nanoparticles require optimization.
Essential Papers
The CRISPR tool kit for genome editing and beyond
Mazhar Adli · 2018 · Nature Communications · 1.6K citations
Abstract CRISPR is becoming an indispensable tool in biological research. Once known as the bacterial immune system against invading viruses, the programmable capacity of the Cas9 enzyme is now rev...
CRISPR/Cas9 in Genome Editing and Beyond
Haifeng Wang, Marie La Russa, Lei S. Qi · 2016 · Annual Review of Biochemistry · 1.2K citations
The Cas9 protein (CRISPR-associated protein 9), derived from type II CRISPR (clustered regularly interspaced short palindromic repeats) bacterial immune systems, is emerging as a powerful tool for ...
Repurposing the CRISPR-Cas9 system for targeted DNA methylation
Aleksandar Vojta, Paula Dobrinić, Vanja Tadić et al. · 2016 · Nucleic Acids Research · 746 citations
Epigenetic studies relied so far on correlations between epigenetic marks and gene expression pattern. Technologies developed for epigenome editing now enable direct study of functional relevance o...
The Nature of Embryonic Stem Cells
Graziano Martello, Austin Smith · 2014 · Annual Review of Cell and Developmental Biology · 445 citations
Mouse embryonic stem (ES) cells perpetuate in vitro the broad developmental potential of naïve founder cells in the preimplantation embryo. ES cells self-renew relentlessly in culture but can reent...
Pioneer Transcription Factors Initiating Gene Network Changes
Kenneth S. Zaret · 2020 · Annual Review of Genetics · 411 citations
Pioneer transcription factors have the intrinsic biochemical ability to scan partial DNA sequence motifs that are exposed on the surface of a nucleosome and thus access silent genes that are inacce...
Genome-Editing Technologies: Principles and Applications
Thomas Gaj, Shannon J. Sirk, Sai-lan Shui et al. · 2016 · Cold Spring Harbor Perspectives in Biology · 397 citations
Targeted nucleases have provided researchers with the ability to manipulate virtually any genomic sequence, enabling the facile creation of isogenic cell lines and animal models for the study of hu...
Engineering the next generation of cell-based therapeutics
Caleb J. Bashor, Isaac B. Hilton, Hozefa S. Bandukwala et al. · 2022 · Nature Reviews Drug Discovery · 372 citations
Reading Guide
Foundational Papers
Start with Martello and Smith (2014, 445 citations) for stem cell epigenome context, then Grimmer et al. (2014) on zinc finger epigenetic modulators as dCas9 precursors.
Recent Advances
Study Vojta et al. (2016, 746 citations) for methylation, Xu et al. (2016, 368 citations) for demethylation, and Bashor et al. (2022, 372 citations) for therapeutic advances.
Core Methods
Core techniques: dCas9 fused to TET1/DNMT3A guided by sgRNAs for locus-specific edits; validated by bisulfite sequencing and ChIP-qPCR as in Choudhury et al. (2016).
How PapersFlow Helps You Research CRISPR Epigenome Editing
Discover & Search
Research Agent uses searchPapers and exaSearch to find Vojta et al. (2016) on targeted methylation, then citationGraph reveals 746 citing papers on dCas9 epigenome tools, and findSimilarPapers uncovers Xu et al. (2016) for demethylation parallels.
Analyze & Verify
Analysis Agent applies readPaperContent to extract TET1 fusion protocols from Choudhury et al. (2016), verifies demethylation efficiency claims with verifyResponse (CoVe) against raw data, and uses runPythonAnalysis for statistical verification of methylation qPCR results via pandas, with GRADE scoring evidence strength.
Synthesize & Write
Synthesis Agent detects gaps like durable editing needs post-Xu et al. (2016), flags contradictions in off-target data across Vojta et al. (2016) and Adli (2018), while Writing Agent uses latexEditText, latexSyncCitations for BRCA1 review sections, and latexCompile for full manuscripts with exportMermaid diagrams of dCas9-epigenome cascades.
Use Cases
"Analyze demethylation efficiency stats from Xu et al. 2016 CRISPR TET1 paper"
Analysis Agent → readPaperContent → runPythonAnalysis (pandas plot of bisulfite sequencing data) → statistical p-values and matplotlib efficiency graphs.
"Write LaTeX review on dCas9 for BRCA1 epigenome editing citing Choudhury 2016"
Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Choudhury et al.) + latexCompile → camera-ready PDF with figure captions.
"Find GitHub code for CRISPR-dCas9 epigenetic modifier simulations"
Research Agent → paperExtractUrls (Adli 2018) → paperFindGithubRepo → githubRepoInspect → runnable Python scripts for off-target prediction models.
Automated Workflows
Deep Research workflow scans 50+ papers via searchPapers on 'dCas9 TET1 demethylation', chains citationGraph to Wang et al. (2016), and outputs structured report on tool evolution. DeepScan's 7-step analysis with CoVe checkpoints verifies Vojta et al. (2016) methods against recent citers. Theorizer generates hypotheses on pioneer factor integration from Zaret (2020) and Martello-Smith (2014).
Frequently Asked Questions
What defines CRISPR Epigenome Editing?
It fuses dCas9 with epigenetic enzymes like DNMT3A or TET1 for targeted modification of DNA methylation or histone marks without double-strand breaks.
What are key methods?
Methods include dCas9-TET1 for demethylation (Xu et al. 2016; Choudhury et al. 2016) and dCas9-DNMT3A for methylation (Vojta et al. 2016), delivered via plasmids or AAV.
What are key papers?
Vojta et al. (2016, 746 citations) on methylation; Xu et al. (2016, 368 citations) on demethylation; Adli (2018, 1585 citations) reviews CRISPR toolkit including epigenome tools.
What open problems exist?
Challenges include off-target effects, achieving durable edits without reversion, and scalable in vivo delivery for therapeutics.
Research CRISPR and Genetic Engineering with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching CRISPR Epigenome Editing with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
Part of the CRISPR and Genetic Engineering Research Guide